What's New

Last Posted: Oct 07, 2024

• Evaluation of the Importance of Genetic Polymorphisms in Genes Expressing Cancer-Metabolizing Enzymes (Cyp1a1 and Gstm1) in Oral Submucous Fibrosis.
  Devina Pradhan, et al. Journal of pharmacy & bioallied sciences 2024 0 (Suppl 3) S2785-S2787
• A scientometric study on research trends and characteristics of oral submucous fibrosis.
  Chengbin Wei, et al. Journal of dental sciences 2024 0 (3) 1834-1839
• TUSC3, p53 and p21 genetic association with development of oral submucous fibrosis and oral squamous cell carcinoma among addictive tobacco chewers of Pakistan.
  Syed Aqib Ali Zaidi, et al. BMC oral health 2024 0 (1) 780
• HLA-DQB1 Allele Polymorphism Associated with Oral Submucous Fibrosis in Hunan, China.
  Yisi Tan, et al. Journal of immunology research 2024 0 8757860
• XRCC3 and NBS1 gene polymorphisms modulate the risk of pre-oral cancer and oral cancer in the North Indian population.
  Nigam Kumud, et al. Journal of cancer research and therapeutics 2023 0 (2) 304-311
• High frequencies of vitamin B12 and folic acid deficiencies and hyperhomocysteinemia in Taiwanese male patients with oral submucous fibrosis.
  Wu Yu-Hsueh, et al. Journal of dental sciences 2023 0 (1) 407-413
• Effect of Frequency and Duration of Tobacco Use on Oral Mucosal Lesions – A Cross-Sectional Study among Tobacco Users in Hyderabad, India.
  Aishwarya K Monisha, et al. Asian Pacific journal of cancer prevention : APJCP 2017 0 (8) 2233-2238
• Risk analysis of malignant potential of oral verrucous hyperplasia: A follow-up study of 269 patients and copy number variation analysis.
  Wu Ming-Heng, et al. Head & neck 2018 0 (5) 1046-1056
• p53 polymorphism and association of human papillomavirus in oral submucous fibrosis and oral squamous cell carcinoma: A case-control study.
  Hallikeri Kaveri, et al. Journal of oral and maxillofacial pathology : JOMFP 2019 0 (1) 97-103
• Single nucleotide polymorphisms and serologic levels of hypoxia-inducible factor1 ? and vascular endothelial growth factor are associated with increased risk of oral submucous fibrosis in gutka users among a North Indian population.
  Gupta Shalini R, et al. Oral surgery, oral medicine, oral pathology and oral radiology 2020 0 (5) 557-564
• Effect of Lysyl Oxidase G473 A Polymorphism on Lysyl Oxidase and Total Soluble Collagen Expression in Oral Submucous Fibrosis.
  Mukherjee Sanjit, et al. Asian Pacific journal of cancer prevention : APJCP 2021 0 (8) 2493-2499
• Association of MICA gene Exon-5 polymorphism in oral submucous fibrosis.
  Jeevankumar Sangeetha, et al. Oral surgery, oral medicine, oral pathology and oral radiology 2022 0 (1) 110-116
• Use of artificial intelligence in diagnosis of head and neck precancerous and cancerous lesions: A systematic review.
  Mahmood H et al. Oral oncology 2020 Jul 110104885
• Genetic Implications of HLA-DR and HLA-DQ Genotype on Tobacco Smoking and Oral Submucous Fibrosis.
  Purohit Abhishek, et al. Oral health & preventive dentistry 2020 0 (3) 455-460
• Risk Modulation of Oral Pre Cancer and Cancer with Polymorphisms in XPD and XPG Genes in North Indian Population.
  Nigam Kumud, et al. Asian Pacific journal of cancer prevention : APJCP 2019 0 (8) 2397-2403
• Variants in FAT1 and COL9A1 genes in male population with or without substance use to assess the risk factors for oral malignancy.
  Chung Chia-Min, et al. PloS one 2019 0 (1) e0210901
• Matrix metalloproteinases-3 gene-promoter polymorphism as a risk factor in oral submucous fibrosis in an Indian population: a pilot study.
  Zade Prajakta R, et al. Journal of investigative and clinical dentistry 2016 7
• Molecular screening of lysyl oxidase G473A polymorphism in oral submucous fibrosis.
  Thorawat Amit, et al. Journal of oral and maxillofacial pathology : JOMFP 2014 5 (2) 207-10
• Mutation Analysis of the Dimer Forming Domain of the Caspase 8 Gene in Oral Submucous Fibrosis and Squamous Cell Carcinomas.
  Menon Uthara, et al. Asian Pacific journal of cancer prevention : APJCP 2015 0 (11) 4589-92
• Role of cytokine gene (interferon-?, transforming growth factor-ß1, tumor necrosis factor-a, interleukin-6, and interleukin-10) polymorphisms in the risk of oral precancerous lesions in Taiwanese.
  Hsu Han-Jen, et al. The Kaohsiung journal of medical sciences 2014 11 (11) 551-8
• The association between miR-499a polymorphism and oral squamous cell carcinoma progression.
  Hou Y-Y, et al. Oral diseases 2015 3 (2) 195-206
• CYP1AI and CYP2E1 gene polymorphisms may increase susceptibility to oral submucous fibrosis among betel quid chewers of eastern India.
  Chaudhuri Susri Ray, et al. Gene 2013 1 (2) 268-71
• Association of CYP1A1, GSTM1, and GSTT1 gene polymorphism with risk of oral submucous fibrosis in a section of North Indian population.
  Ghosh Tanima, et al. Molecular biology reports 2012 10 (10) 9383-9
• Association of XRCC1, XRCC3, and NAT2 polymorphisms with the risk of oral submucous fibrosis among eastern Indian population.
  Mukherjee Sanjit, et al. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2012 4 (4) 292-302
• Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population.
  Chaudhary Ajay Kumar, et al. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2011 11 (7) 577-86
• Role of GSTM1 and GSTT1 polymorphism: susceptibility to oral submucous fibrosis in the North Indian population.
  Agrawal Deepa, et al. Oncology 2010 0 (3-4) 181-6
• Oral submucous fibrosis
  From NCATS Genetic and Rare Diseases Information Center
• Transforming growth factor-ß-1 polymorphisms are infrequent but exist at selected loci in oral submucous fibrosis.
  Rajendran R, et al. Indian journal of dental research : official publication of Indian Society for Dental Research 0 0 (3) 413-9
• Functional polymorphism of the MMP-1 promoter (-1607 1G/2G) in potentially malignant and malignant head and neck lesions in an Indian population.
  Chaudhary Ajay Kumar, et al. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2010 12 (8) 684-92
• Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions.
  Chaudhary Ajay K, et al. BMC cancer 2010 0 (1) 369
• Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
  Wang Li-Hsuan, et al. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2010 2 (2) 155-61
• GST null genotype and antioxidants: risk indicators for oral pre-cancer and cancer.
  Bathi Renuka J, et al. Indian journal of dental research : official publication of Indian Society for Dental Research 0 0 (3) 298-303
• Association between lysyl oxidase polymorphisms and oral submucous fibrosis in older male areca chewers.
  Shieh Tzong-Ming, et al. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2009 1 (1) 109-13
• The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase 3 gene as a risk factor for oral submucous fibrosis among male areca users.
  Tu H-F, et al. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2006 2 (2) 99-103
• Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas.
  Lin Shu-Chun, et al. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2004 7 (6) 323-6
• Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis.
  Lin Shu-Chun, et al. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2004 8 (7) 405-9
• Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers.
  Chang K-W, et al. British journal of cancer 2004 10 (8) 1551-5
• Association of CTLA-4 gene polymorphism with oral submucous fibrosis in Taiwan.
  Shin YN, et al. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2004 4 (4) 200-3
• HLA typing in Taiwanese patients with oral submucous fibrosis.
  Chen HM, et al. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2004 4 (4) 191-9
• Polymorphism of the MICA gene and risk for oral submucous fibrosis.
  Liu Chung-Ji, et al. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2004 1 (1) 1-6
• Association between genetic polymorphism of tumor necrosis factor-alpha and risk of oral submucous fibrosis, a pre-cancerous condition of oral cancer.
  Chiu C J, et al. Journal of dental research 2001 12 (12) 2055-9
• Interaction of collagen-related genes and susceptibility to betel quid-induced oral submucous fibrosis.
  Chiu Chung-Jung, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 7 (7) 646-53